Literature DB >> 9875334

Emergence of epidemic O'nyong-nyong fever in Uganda after a 35-year absence: genetic characterization of the virus.

R S Lanciotti1, M L Ludwig, E B Rwaguma, J J Lutwama, T M Kram, N Karabatsos, B C Cropp, B R Miller.   

Abstract

O'nyong-nyong (ONN) virus is an alphavirus (family Togaviridae, genus Alphavirus) classified in the Semliki Forest virus (SFV) antigenic complex. ONN was initially isolated in northern Uganda in 1959 during the early stages of an explosive arbovirus epidemic in which > 2 million cases were reported. No additional epidemics or human isolations of ONN were reported until 1996, when it was isolated from an epidemic in southern Uganda. We report the complete nucleotide and deduced amino acid sequence of one of these 1996-1997 ONN isolates (SG650) and that of the related alphavirus Igbo Ora virus. The data indicate that the recent ONN virus isolate is closely related to the previously published ONN strain isolated in 1959. In addition, phylogenetic analysis of the sequence data reveals that Igbo Ora virus, previously thought to be a separate virus closely related to ONN and Chikungunya (CHIK), clearly is a strain of ONN. The sequence data also reveal that unlike the published ONN (1959) sequence, all ONN strains from the 1996-1997 epidemic possess a stop codon at the nsp3-nsp4 junction.

Entities:  

Mesh:

Year:  1998        PMID: 9875334     DOI: 10.1006/viro.1998.9437

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  Sequence requirements for Sindbis virus subgenomic mRNA promoter function in cultured cells.

Authors:  M M Wielgosz; R Raju; H V Huang
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells.

Authors:  S C Weaver; A C Brault; W Kang; J J Holland
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Evolutionary relationships and systematics of the alphaviruses.

Authors:  A M Powers; A C Brault; Y Shirako; E G Strauss; W Kang; J H Strauss; S C Weaver
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Development of a Real-Time Reverse Transcription Polymerase Chain Reaction for O'nyong-nyong Virus and Evaluation with Clinical and Mosquito Specimens from Kenya.

Authors:  Jesse Waggoner; Claire Jane Heath; Bryson Ndenga; Francis Mutuku; Malaya K Sahoo; Alisha Mohamed-Hadley; John Vulule; Dunstan Mukoko; A Desiree LaBeaud; Benjamin A Pinsky
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

5.  Replicase complex genes of Semliki Forest virus confer lethal neurovirulence.

Authors:  M T Tuittila; M G Santagati; M Röyttä; J A Määttä; A E Hinkkanen
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Effects of an opal termination codon preceding the nsP4 gene sequence in the O'Nyong-Nyong virus genome on Anopheles gambiae infectivity.

Authors:  Kevin M Myles; Cindy L H Kelly; Jeremy P Ledermann; Ann M Powers
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Mosquitoes of Zika Forest, Uganda: species composition and relative abundance.

Authors:  M A Kaddumukasa; J-P Mutebi; J J Lutwama; C Masembe; A M Akol
Journal:  J Med Entomol       Date:  2014-01       Impact factor: 2.278

Review 8.  O'nyong-nyong fever: a neglected mosquito-borne viral disease.

Authors:  Giovanni Rezza; Rubing Chen; Scott C Weaver
Journal:  Pathog Glob Health       Date:  2017-08-22       Impact factor: 2.894

9.  Next generation sequencing of DNA-launched Chikungunya vaccine virus.

Authors:  Rachmat Hidajat; Brian Nickols; Naomi Forrester; Irina Tretyakova; Scott Weaver; Peter Pushko
Journal:  Virology       Date:  2016-02-06       Impact factor: 3.616

10.  Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.

Authors:  Byungki Cho; Bo-Young Jeon; Jungho Kim; Jaesang Noh; Jiha Kim; Minjung Park; Sun Park
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.